With positive results, Eli Lilly can begin assembling the application immediately
Tapering off is when you slowly lower your dose or stretch out your dose frequency
In a 48-week phase 2 trial published in The New England Journal of Medicine , adults with obesity (without type 2 diabetes) receiving once-weekly subcutaneous retatrutide at the 12 mg amount achieved a least-squares mean body weight reduction of 24.2%, compared with 2.1% in the placebo group [1]
02 Meet with our expert team to discuss your goals, explore options, and design a customized treatment plan that supports both confidence and wellness
Metabolic Impact Retatrutide improves the bodys ability to utilize glucose, allowing it to maintain better blood sugar control even in those without diabetes
It is particularly helpful for individuals struggling with weight management because it encourages feelings of fullness